Publications by authors named "Marc Usart"

Claim this Profile
L
Loss of Socs2 improves molecular responses to IFNα in a mouse model of myeloproliferative neoplasms driven by JAK2-V617F.
Marc Usart, Quentin Kimmerlin, Jan Stetka, Cédric Stoll, Shivam Rai

Leukemia· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of Dnmt3a increases self-renewal and resistance to pegIFN-α in JAK2-V617F-positive myeloproliferative neoplasms.
Marc Usart, Jan Stetka, Damien Luque Paz, Nils Hansen, Quentin Kimmerlin

Blood· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN.
Marc Usart, Nils Hansen, Jan Stetka, Tiago Almeida Fonseca, Alexandre Guy

Blood Adv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells.
Shivam Rai, Yang Zhang, Elodie Grockowiak, Quentin Kimmerlin, Nils Hansen, Marc Usart

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron is a modifier of the phenotypes of JAK2-mutant myeloproliferative neoplasms.
Jan Stetka, Marc Usart, Lucia Kubovcakova, Shivam Rai, Tata Nageswara Rao

Blood· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell lineage tracing unveils a role for TCF15 in haematopoiesis.
Alejo E Rodriguez-Fraticelli, Caleb Weinreb, Shou-Wen Wang, Rosa P Migueles, Maja Jankovic, Marc Usart

Nature· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis